CRISPR

CRISPR2-gucy1a1

ID

ZDB-CRISPR-211201-1

Name

CRISPR2-gucy1a1

Previous Names

None

Target

gucy1a1 (1)

Sequence

5' - GGGCGAATGCCCCTTTTCTA - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
zf3477	gucy1a1

Expression

Gene expression in Wild Types + CRISPR2-gucy1a1

No data available

Phenotype

Phenotype resulting from CRISPR2-gucy1a1

No data available

Phenotype of all Fish created by or utilizing CRISPR2-gucy1a1

Phenotype	Fish	Conditions	Figures
blood circulation increased linear velocity, abnormal	gucy1a1^{zf3477/zf3477} (AB)	standard conditions	FIGURE 2 from Vishnolia et al., 2021
blood vessel increased diameter, abnormal	gucy1a1^{zf3477/zf3477} (AB)	standard conditions	FIGURE 2 from Vishnolia et al., 2021
whole organism gucy1a1 expression decreased amount, abnormal	gucy1a1^{zf3477/zf3477} (AB)	standard conditions	FIGURE 1 from Vishnolia et al., 2021
blood circulation increased rate, abnormal	gucy1a1^{zf3477/zf3477} (AB)	standard conditions	FIGURE 2 from Vishnolia et al., 2021
heart contraction increased frequency, abnormal	gucy1a1^{zf3477/zf3477} (AB)	standard conditions	FIGURE 2 from Vishnolia et al., 2021
blood circulation increased magnitude, abnormal	gucy1a1^{zf3477/zf3477} (AB)	standard conditions	FIGURE 2 from Vishnolia et al., 2021
blood circulation increased linear velocity, abnormal	gucy1a1^zf3477/+ (AB)	standard conditions	FIGURE 2 , FIGURE 3 from Vishnolia et al., 2021
heart contraction increased frequency, abnormal	gucy1a1^zf3477/+ (AB)	standard conditions	FIGURE 2 from Vishnolia et al., 2021
whole organism gucy1a1 expression decreased amount, abnormal	gucy1a1^zf3477/+ (AB)	standard conditions	FIGURE 1 from Vishnolia et al., 2021
blood circulation increased rate, abnormal	gucy1a1^zf3477/+ (AB)	standard conditions	FIGURE 2 , FIGURE 3 from Vishnolia et al., 2021
blood circulation increased magnitude, abnormal	gucy1a1^zf3477/+ (AB)	standard conditions	FIGURE 2 , FIGURE 3 from Vishnolia et al., 2021
blood vessel increased diameter, abnormal	gucy1a1^zf3477/+ (AB)	standard conditions	FIGURE 2 , FIGURE 3 from Vishnolia et al., 2021
whole organism 3',5'-cyclic GMP increased amount, abnormal	gucy1a1^zf3477/+ (AB)	chemical treatment by environment: BAY 41-2272	FIGURE 4 from Vishnolia et al., 2021
blood circulation increased linear velocity, abnormal	gucy1a1^zf3477/+ + MO1-cct7 (AB)	standard conditions	FIGURE 3 from Vishnolia et al., 2021
blood vessel increased diameter, abnormal	gucy1a1^zf3477/+ + MO1-cct7 (AB)	standard conditions	FIGURE 3 from Vishnolia et al., 2021
blood circulation increased rate, abnormal	gucy1a1^zf3477/+ + MO1-cct7 (AB)	standard conditions	FIGURE 3 from Vishnolia et al., 2021
blood circulation increased magnitude, abnormal	gucy1a1^zf3477/+ + MO1-cct7 (AB)	standard conditions	FIGURE 3 from Vishnolia et al., 2021

Citations